YouthBio Therapeutics


Organization Description

Founded by investors Yuri Deigin and Viet Ly and with Dr. João Pedro de Magalhães as its Chief Scientific Officer, YouthBio Therapeutics focuses on gene therapies that induce epigenetic rejvuenation. The company has exited stealth mode as of April 14, 2022 and has not yet announced the full details of its upcoming therapies.


Yuri Deigin

YouthBio Therapeutics - Co-Founder and Director